vs
Astrana Health, Inc.(ASTH)とTSS, Inc.(TSSI)の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい($950.5M vs $60.9M、TSS, Inc.の約15.6倍)。TSS, Inc.の純利益率が高く(20.0% vs 0.7%、差は19.3%)。Astrana Health, Inc.の前年同期比売上増加率が高い(42.9% vs 21.8%)。TSS, Inc.の直近四半期フリーキャッシュフローが多い($15.8M vs $-6.0M)。過去8四半期でTSS, Inc.の売上複合成長率が高い(95.8% vs 53.3%)
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
ASTH vs TSSI — 直接比較
売上が大きい
ASTH
15.6倍大きい
$60.9M
売上成長率が高い
ASTH
+21.1%の差
21.8%
純利益率が高い
TSSI
純利益率が19.3%高い
0.7%
フリーキャッシュフローが多い
TSSI
FCF $21.7M多い
$-6.0M
2年売上CAGRが高い
TSSI
2年複合成長率
53.3%
損益計算書 — Q4 2025 vs Q4 2025
| 指標 | ||
|---|---|---|
| 売上 | $950.5M | $60.9M |
| 純利益 | $6.6M | $12.2M |
| 粗利率 | — | 17.6% |
| 営業利益率 | 1.9% | 1.5% |
| 純利益率 | 0.7% | 20.0% |
| 売上前年比 | 42.9% | 21.8% |
| 純利益前年比 | 184.4% | 535.7% |
| EPS(希薄化後) | $0.12 | $0.44 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上
ASTH
TSSI
| Q4 25 | $950.5M | $60.9M | ||
| Q3 25 | $956.0M | $41.9M | ||
| Q2 25 | $654.8M | $44.0M | ||
| Q1 25 | $620.4M | $99.0M | ||
| Q4 24 | $665.2M | $50.0M | ||
| Q3 24 | $478.7M | $70.1M | ||
| Q2 24 | $486.3M | $12.2M | ||
| Q1 24 | $404.4M | $15.9M |
純利益
ASTH
TSSI
| Q4 25 | $6.6M | $12.2M | ||
| Q3 25 | $373.0K | $-1.5M | ||
| Q2 25 | $9.4M | $1.5M | ||
| Q1 25 | $6.7M | $3.0M | ||
| Q4 24 | $-7.8M | $1.9M | ||
| Q3 24 | $16.1M | $2.6M | ||
| Q2 24 | $19.2M | $1.4M | ||
| Q1 24 | $14.8M | $15.0K |
粗利率
ASTH
TSSI
| Q4 25 | — | 17.6% | ||
| Q3 25 | — | 11.1% | ||
| Q2 25 | — | 17.8% | ||
| Q1 25 | — | 9.3% | ||
| Q4 24 | — | 14.4% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 37.3% | ||
| Q1 24 | — | 17.1% |
営業利益率
ASTH
TSSI
| Q4 25 | 1.9% | 1.5% | ||
| Q3 25 | 2.0% | -2.2% | ||
| Q2 25 | 3.1% | 5.1% | ||
| Q1 25 | 3.3% | 4.2% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 5.9% | 5.4% | ||
| Q2 24 | 6.2% | 14.0% | ||
| Q1 24 | 7.5% | 1.6% |
純利益率
ASTH
TSSI
| Q4 25 | 0.7% | 20.0% | ||
| Q3 25 | 0.0% | -3.6% | ||
| Q2 25 | 1.4% | 3.4% | ||
| Q1 25 | 1.1% | 3.0% | ||
| Q4 24 | -1.2% | 3.8% | ||
| Q3 24 | 3.4% | 3.8% | ||
| Q2 24 | 3.9% | 11.5% | ||
| Q1 24 | 3.7% | 0.1% |
EPS(希薄化後)
ASTH
TSSI
| Q4 25 | $0.12 | $0.44 | ||
| Q3 25 | $0.01 | $-0.06 | ||
| Q2 25 | $0.19 | $0.06 | ||
| Q1 25 | $0.14 | $0.12 | ||
| Q4 24 | $-0.14 | $0.08 | ||
| Q3 24 | $0.33 | $0.10 | ||
| Q2 24 | $0.40 | $0.06 | ||
| Q1 24 | $0.31 | $0.00 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $85.5M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $779.3M | $76.6M |
| 総資産 | $2.2B | $184.9M |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資
ASTH
TSSI
| Q4 25 | $429.5M | $85.5M | ||
| Q3 25 | $463.4M | $70.7M | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | $23.2M | ||
| Q3 24 | $350.3M | $46.4M | ||
| Q2 24 | $327.7M | $8.3M | ||
| Q1 24 | $337.3M | $14.4M |
株主資本
ASTH
TSSI
| Q4 25 | $779.3M | $76.6M | ||
| Q3 25 | $775.5M | $63.4M | ||
| Q2 25 | $765.5M | $9.5M | ||
| Q1 25 | $745.4M | $9.4M | ||
| Q4 24 | $712.7M | $7.1M | ||
| Q3 24 | $704.6M | $7.7M | ||
| Q2 24 | $678.9M | $5.2M | ||
| Q1 24 | $653.5M | $3.7M |
総資産
ASTH
TSSI
| Q4 25 | $2.2B | $184.9M | ||
| Q3 25 | $2.2B | $165.4M | ||
| Q2 25 | $1.4B | $139.5M | ||
| Q1 25 | $1.3B | $113.5M | ||
| Q4 24 | $1.4B | $96.6M | ||
| Q3 24 | $1.3B | $67.3M | ||
| Q2 24 | $1.3B | $28.9M | ||
| Q1 24 | $1.2B | $26.8M |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $16.3M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $15.8M |
| FCFマージンFCF / 売上 | -0.6% | 25.9% |
| 設備投資強度設備投資 / 売上 | 0.3% | 0.9% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 1.34× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $2.1M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフロー
ASTH
TSSI
| Q4 25 | $-2.9M | $16.3M | ||
| Q3 25 | $10.0M | $-18.4M | ||
| Q2 25 | $90.9M | $16.3M | ||
| Q1 25 | $16.6M | $20.6M | ||
| Q4 24 | $-10.9M | $-21.6M | ||
| Q3 24 | $34.0M | $38.6M | ||
| Q2 24 | $23.2M | $-4.3M | ||
| Q1 24 | $6.0M | $2.6M |
フリーキャッシュフロー
ASTH
TSSI
| Q4 25 | $-6.0M | $15.8M | ||
| Q3 25 | $7.4M | $-24.9M | ||
| Q2 25 | $89.5M | $5.4M | ||
| Q1 25 | $13.6M | $5.8M | ||
| Q4 24 | $-13.5M | $-28.4M | ||
| Q3 24 | $31.7M | $38.6M | ||
| Q2 24 | $20.4M | $-6.0M | ||
| Q1 24 | $5.6M | $2.6M |
FCFマージン
ASTH
TSSI
| Q4 25 | -0.6% | 25.9% | ||
| Q3 25 | 0.8% | -59.3% | ||
| Q2 25 | 13.7% | 12.3% | ||
| Q1 25 | 2.2% | 5.8% | ||
| Q4 24 | -2.0% | -56.7% | ||
| Q3 24 | 6.6% | 55.1% | ||
| Q2 24 | 4.2% | -49.4% | ||
| Q1 24 | 1.4% | 16.4% |
設備投資強度
ASTH
TSSI
| Q4 25 | 0.3% | 0.9% | ||
| Q3 25 | 0.3% | 15.3% | ||
| Q2 25 | 0.2% | 24.8% | ||
| Q1 25 | 0.5% | 15.0% | ||
| Q4 24 | 0.4% | 13.4% | ||
| Q3 24 | 0.5% | 0.1% | ||
| Q2 24 | 0.6% | 13.8% | ||
| Q1 24 | 0.1% | 0.2% |
キャッシュ転換率
ASTH
TSSI
| Q4 25 | -0.44× | 1.34× | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 11.02× | ||
| Q1 25 | 2.48× | 6.93× | ||
| Q4 24 | — | -11.32× | ||
| Q3 24 | 2.11× | 14.60× | ||
| Q2 24 | 1.21× | -3.09× | ||
| Q1 24 | 0.40× | 176.40× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
TSSI
| Procurement Revenues Segment | $43.2M | 71% |
| System Integration Services Segment | $14.2M | 23% |
| Facilities Segment | $3.5M | 6% |